Background: Combination drug therapy is often used to achieve optimal analgesia in surgery. Paracetamol can be used as one component of an analgesic regime following hepatic resection. Objective: This study was designed to investigate paracetamol and its metabolites by proton NMR spectroscopy in patient urine and to assess whether N-acetyl-p-benzoquinone imine (NAPQI, a hepatotoxic metabolite) formation is increased after liver resection. Method: We studied the excretion of acetaminophen and its metabolites by 5 patients who were operated on for partial liver resection by proton NMR spectroscopy. As an intravenous infusion 1 g of paracetamol was given over 15 min every 6 h during 48 h. The first injection was given in the operating theatre after liver resection was completed. Urine samples were collected before injection (T1) and 24 and 48 h after the first injection (T2 and T3); the samples were frozen and kept at -20°C up to the analysis by NMR spectroscopy. Results: Metabolites of the paracetamol were detected for all patients. Among the discerned metabolites, 4 were identified as metabolites of paracetamol: paracetamol glucuronide, paracetamol sulfate, N-acetyl-L- cysteinyl paracetamol (metabolite of NAPQI) and paracetamol. Their ratios, respectively, were: 46-82.9, 12.6-30.0, 0.5-5.5 and 1.43-3.54%. Conclusion: This study showed that there was no increase in the formation of toxic metabolite (NAPQI) after treatment with paracetamol in these few cases of liver resections. A larger study is necessary to confirm these results.

Keywords:
Partial liver resection, Proton NMR spectroscopy, Paracetamol, Metabolites
1.
Kehlet H, Dahl JB: The value of multimodal or balanced analgesia in postoperative pain treatment. Anesth Analg 1993;77:1048-1056.
2.
Mimoz O, Incagnoli P, Josse C, Gillon MC, Kulhman L, Mirard A, Soilleux H, Fletcher D: Analgesic efficacy and safety of nefopam vs. propacetamol following hepatic resection. Anesthesia 2001;56:520-525.
3.
Galinski M, Delhotal-Landes B, Lockey DJ, Rouaud J, Bah S, Bossard AE, Lapostolle F, Chauvin M, Adnet F: Reduction of paracetamol metabolism after hepatic resection. Pharmacology 2006;77:161-165.
4.
Forrest J, Clements J, Prescott L: Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet 1982;7:93-107.
5.
Bales JR, Sadler PJ, Nicholson JK, Timbrell JA: Urinary excretion of acetaminophen and its metabolites as studied by proton NMR spectroscopy. Clin Chem 1984;30:1631-1636.
6.
Steventon GB, Mitchell SC, Warinq RH: Human metabolism of paracetamol at different dose levels. Drug Metabol Drug Interact 1996;13:111-117.
7.
Nelson S: Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin Liver Dis 1990;10:267-278.
8.
Park JM, Lin YS, Calamia JC, Thummel KE, Slattery JT, Kalhorn TF, Carithers RL, Levy AE, Marsh CL, Hebert MF: Transiently altered acetaminophen metabolism after liver transplantation. Clin Pharmacol Ther 2003;73:545-553.
9.
Prescott LF: Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs 1983;25:290-314.
10.
Slattery JT, Levy G: Acetaminophen kinetics in acutely poisoned patients. Clin Pharmacol Ther 1979;25:184-195.
11.
Thummel KE, Slattery JT, Ro H, Chien JY, Nelson SD, Lown KE, et al: Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults. Clin Pharmacol Ther 2000;67:591-599.
12.
Burckart GJ, Frye RF, Kelly P, Branch RA, Jain A, Fung JJ, et al: Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation. Clin Pharmacol Ther 1998;63:296-302.
13.
Shiratori Y, Kiriyama H, Fukushji Y, et al: Modulation of ischemia-reperfusion-induced hepatic injury by Kupffer cells. Dig Dis Sci 1994;39:1265-1272.
14.
Jaeschke H: Mechanism of reperfusion injury after warm ischemia of the liver. J Hepatobilary Pancreat Surg 1998;5:402-408.
15.
Kobayashi H, Kurokawa T, Kitahara S, Nonami T, Harada A: The effects of gamma-glutamylcysteine ethyl esther, a prodrug of glutathione, on ischemia-reperfusion-induced liver injury in rats. Transplantation 1993;56:256-257.
16.
Belghiti J, Noun R, Zante E, Ballet T, Sauvanet A: Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg 1996;224:155-161.
17.
Kobayashi H, Nonami T, Kurokawa T, Sugiyama S, Ozawa T, Takagi H: Effect of preceding ischemic time on the recovery course of energy metabolism in rat liver. Biochem Intern 1990;22:227-233.
18.
Bales JR, Higham DP, Howe I, et al: High-resolution proton NMR spectroscopy for rapid muti-component analysis of urine. Clin Chem 1984;30:426-432.
19.
Nicholson JK, O'Flynn MP, Sadler PJ, et al: Proton NMR studies of serum, plasma and urine from fasting normal and diabetic subjects. Biochem J 1984;217:365-375.
20.
Bales JR, Bell JD, Nicholson JK, Saddler PJ, Timbrell JA, Hughes RD, Bennett PN, Williams R: Metabolic profiling of body by proton NMR: self-poisoning episodes with paracetamol (acetaminophen). Magn Reson Med 1988;6:300-306.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.